Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
HCP calling to report an AE regarding the PNEUMOVAX 23 vaccine. HCP reported that a patient had a severe local reaction where their whole upper arm was very red and painful for a couple of days after administration of the PNEUMOVAX 23 vaccine. HCP st; HCP calling to report an AE regarding the PNEUMOVAX 23 vaccine. HCP reported that a patient had a severe local reaction where their whole upper arm was very red and painful for a couple of days after administration of the PNEUMOVAX 23 vaccine. HCP st; This spontaneous report was received from a pharmacist concerning a 57-year-old female patient. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On unspecified date in January 2020 (reported as ''5 years ago''), the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), (strength, route, anatomical location, lot # and expiration date were not reported) for the treatment of prophylaxis. On unspecified date in January 2020 (reported as ''5 years ago''), the patient had a severe local reaction where their whole upper arm was very red and painful (vaccination site erythema and vaccination site pain) for a couple of days after administration of the Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) vaccine. The patient did not develop any hives. At the reporting time, the outcome of the events was unknown. The causality was not provided. Lot # is being requested and will be submitted if received.